A targetable SWI/SNF dependency sustains survival in pediatric B-ALL
Pediatric B-cell acute lymphoblastic leukemia (B-ALL) remains a major clinical challenge driven by molecular heterogeneity and therapeutic resistance. While the SWI/SNF chromatin-remodeling complex is a recognized dependency in myeloid and T-cell leukemias, its role in B-ALL remains poorly defined. Here, we identify a conserved requirement for the SWI/SNF ATPases SMARCA4 and SMARCA2 across diverse B-ALL genetic subtypes. SMARCA4 expression correlates with inferior overall survival in the pediatric B-ALL TARGET cohort. Using a panel of B-ALL models representing ETV6-RUNX1, BCR-ABL1, and KMT2A-rearranged subtypes, we show that dual SMARCA2/4 inhibition, using the ATPase inhibitor BRM014 or the PROTAC degrader ACBI1, induces profound loss of viability. This vulnerability is characterized by G0/G1 cell cycle arrest and a robust apoptotic response. Mechanistically, comparative RNA sequencing identified a high-confidence 26-gene "identity core" consistently downregulated upon SWI/SNF disruption with BRM014. This program integrates lymphocyte activation, cytokine signaling, and trafficking modules, including the key niche-interaction receptor CXCR4, and is accompanied by depletion of MYC and E2F transcriptional programs. Finally, BRM014 demonstrated significant growth-inhibitory activity in vivo in an REH xenograft model, with a significant delay in disease progression during the observation window. These findings establish the SWI/SNF complex as a conserved survival dependency in the tested B-ALL models and provide a rationale for targeting SMARCA2/4 to inhibit intrinsic growth in B-ALL.
Authors
- Pedro P. Medina (ORCID: https://orcid.org/0000-0002-7834-7093)
- Juan de los Santos-Jiménez (ORCID: https://orcid.org/0000-0003-3495-047X)
- Sergio Castro‐Gonzalez (ORCID: https://orcid.org/0000-0003-4083-7879)
- Fernando Montenegro-Elvira (ORCID: https://orcid.org/0000-0001-5611-5120)
Institutions
- Universidad de Granada (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (ES)
Publication Details
- Journal
- Experimental Hematology and Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1186/s40164-026-00847-4
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Junta de Andalucía
- European Regional Development Fund
- Agencia Estatal de Investigación
- European Social Fund